R Squared’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

R Squared’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-89,866	Closed	-$22.2K	–	676
2026 Q1	$22.2K	Sell	89,866 -57,325	-39%	-$22.8K	0.01%	463
2025 Q4	$61.8K	Buy	147,191 +26,732	+22%	+$14.2K	0.03%	447
2025 Q3	$81.1K	Buy	120,459 +68,000	+130%	+$36.7K	0.03%	448
2025 Q2	$28.4K	Buy	+52,459	New	+$31.1K	0.02%	426

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

R Squared's SGMO Position: Q2 2026 in Review

R Squared sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 89,866 shares — an estimated $22.2K sold.

R Squared first reported a position in SGMO in Q2 2025 and held it in 4 quarters. The position peaked at $81.1K in Q3 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

R Squared reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
R Squared sold 89,866 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $22.2K.
R Squared first reported a position in SANGAMO THERAPEUTICS INC in Q2 2025 and held it in 4 quarters.
R Squared's SANGAMO THERAPEUTICS INC position peaked at $81.1K in Q3 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.